Sinopharm Group Co. Ltd.
SHTDYOTCHealthcare● Active
$10.90
+$0.02(+0.18%)
Market Cap$6.8B
P/E Ratio—
52W High$14.87
52W Low$10.57
Sinopharm Group Co. Ltd. (SHTDY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SHTDY · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 23, 2026EPS Actual
$0.83
Revenue
$40.57B
Est. $40.57B · +0.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 23, 2026
After Market Close
SHTDY reports quarterly as a OTC-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 23, 2026 | — | $0.83 | — | $40.57B | $40.57B | +0.0% |
| — Q3 FY2025 | Aug 28, 2025 | — | $0.77 | — | $39.89B | — | — |
| ◌ Q2 FY2025 | Apr 25, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 21, 2025 | — | — | — | — | $150.1B | — |
| ◌ Q4 FY2024 | Oct 25, 2024 | — | — | — | — | — | — |
| — Q3 FY2024 | Aug 23, 2024 | — | $0.10 | — | $20.29B | — | — |
| — Q2 FY2024 | Apr 26, 2024 | — | $0.06 | — | $20.36B | — | — |
| — Q1 FY2024 | Mar 22, 2024 | — | $0.09 | — | $19.84B | — | — |
Q2 FY2026
Apr 23, 2026
EPS Actual
$0.83
EPS Est.
—
EPS Surpr.
—
Revenue
$40.57B
Q3 FY2025
Aug 28, 2025
EPS Actual
$0.77
EPS Est.
—
EPS Surpr.
—
Revenue
$39.89B
Q2 FY2025
Apr 25, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 21, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Oct 25, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 23, 2024
EPS Actual
$0.10
EPS Est.
—
EPS Surpr.
—
Revenue
$20.29B
Q2 FY2024
Apr 26, 2024
EPS Actual
$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$20.36B
Q1 FY2024
Mar 22, 2024
EPS Actual
$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$19.84B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $284B | $284B | $284B | 1 |
| Q3 FY2025 | $286B | $286B | $286B | 1 |
| Q2 FY2025 | $144B | $144B | $144B | 1 |
| Q1 FY2025 | $142B | $142B | $142B | 1 |
| Q4 FY2024 | $142B | $142B | $142B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | Apr 23, 2026 | — | $12.64 | $12.41 | -1.82% |
| — Q3 FY2025 | Aug 28, 2025 | — | $12.04 | $11.91 | -1.08% |
| — Q3 FY2024 | Aug 23, 2024 | — | $11.86 | $11.86 | +0.00% |
| — Q2 FY2024 | Apr 26, 2024 | — | $13.88 | $13.74 | -1.01% |
| — Q1 FY2024 | Mar 22, 2024 | — | $13.32 | $13.11 | -1.58% |
| — Q4 FY2023 | Dec 31, 2023 | — | $13.05 | $12.83 | -1.69% |
| — Q2 FY2023 | Jun 30, 2023 | — | $15.37 | $15.55 | +1.17% |
| — Q1 FY2023 | Mar 31, 2023 | — | $14.64 | $14.89 | +1.71% |
Q2 FY2026-1.82%
Report Date
Apr 23, 2026
EPS Beat/Miss
—
Price Before
$12.64
Price After
$12.41
Q3 FY2025-1.08%
Report Date
Aug 28, 2025
EPS Beat/Miss
—
Price Before
$12.04
Price After
$11.91
Q3 FY2024+0.00%
Report Date
Aug 23, 2024
EPS Beat/Miss
—
Price Before
$11.86
Price After
$11.86
Q2 FY2024-1.01%
Report Date
Apr 26, 2024
EPS Beat/Miss
—
Price Before
$13.88
Price After
$13.74
Q1 FY2024-1.58%
Report Date
Mar 22, 2024
EPS Beat/Miss
—
Price Before
$13.32
Price After
$13.11
Q4 FY2023-1.69%
Report Date
Dec 31, 2023
EPS Beat/Miss
—
Price Before
$13.05
Price After
$12.83
Q2 FY2023+1.17%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$15.37
Price After
$15.55
Q1 FY2023+1.71%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$14.64
Price After
$14.89
Beat Rate0 / 8 quarters
Largest Move-1.82% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SHTDY ends December
Sinopharm Group Co. Ltd. (SHTDY) most recently reported earnings on April 23, 2026 for Q2 FY2026, posting EPS of $0.83 (in line with the analyst consensus of —). The next SHTDY earnings date is expected around September 1, 2026.
Each quarter, investors track SHTDY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SHTDY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SHTDY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SHTDY earnings · 4 questionsSinopharm Group Co. Ltd.'s next earnings report is expected around September 1, 2026. SHTDY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SHTDY historically reports after market close (AMC).
SHTDY earnings datewhen is SHTDY earningsSHTDY next earnings datewhen does SHTDY report earningsSHTDY earnings calendar
▸ Source: FMP · Sinopharm Group Co. Ltd. SEC filings · US GAAP · Sinopharm Group Co. Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026